Biote's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Biote (BTMD) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Biote vs Its Competitors
- TTM: Trailing 12-month revenue of 184M vs -M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-3.6% annualized vs trailing 12 months).
- Scale: Biote ranks #13 of 36 companies by market capitalization in the Legal Cannabis industry, holding 0.3% of industry market cap.
- Peer revenue share: Biote accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
- Structure: Biote operates in the following segments: Single Reporting Segment.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
BTMD Sales vs. its Competitors, Q2 2026
Biote generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Legal Cannabis industry grew revenue 21.4% year over year, combined, vs -9.5% for Biote. Biote's share of combined industry revenue moved from 1.89% to 1.41%, a loss of 0.48 percentage points.
Biote's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Biote Corp | Yes | No | No | No |
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 12.50 % (1 of 8) | 62.50 % (5 of 8) | 50.00 % (4 of 8) | 28.60 % (2 of 7) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
BTMD Stock Performance relative to its Competitors
BTMD Stock Performance relative to Similar-Size Competitors
BTMD Stock Performance relative to Similar Growth & Profitability Competitors
Biote's Comment on Competition and Industry Peers
Biote's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Biote Corp | Single Reporting Segment 100.00 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).